BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
弥合信息鸿沟和差距,确保生存:旨在提高儿童癌症生存依从性的多层次干预的 BRIDGES 随机对照试验
基本信息
- 批准号:10491902
- 负责人:
- 金额:$ 57.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-21 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAgeBlack raceCOVID-19 pandemicCancer CenterCancer SurvivorshipCaringChemotherapy and/or radiationClinicCollaborationsCommon Terminology Criteria for Adverse EventsCommunicationCommunitiesConsensusDiagnosisDissemination and ImplementationEducationElectronic Health RecordEligibility DeterminationEnrollmentEnsureExplosionGoalsGoldGuidelinesHealthInstitutionInsuranceInteractive CommunicationInterventionInterviewKnowledgeLate EffectsLatinxLifeMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMedical RecordsMethodsModelingMonitoring for RecurrenceOncologistOutcomePatient CarePatient EducationPatient-Focused OutcomesPatientsPersonsPhysiciansPrimary Health CareProcessQuality of CareRandomizedRandomized Controlled TrialsRecommendationResourcesRuralSamplingSelf EfficacyServicesSiteStructureSubgroupSurveysTechnologyTelephoneTestingText MessagingTravelVisitWorkacceptability and feasibilityadherence ratearmbasecancer therapycare providerschildhood cancer survivorcommunity centercomparison groupcostfollow-upfuture implementationhealth disparityimprovedindividual patientinnovationinstrumentintervention participantsmedical specialtiespatient health informationpatient portalpreferenceprimary endpointprimary outcomeprogramsprovider-level barrierssocioeconomic disadvantagesurvivorshiptelehealthtumor
项目摘要
PROJECT SUMMARY
More than 80% of childhood cancer survivors (CCS) develop serious or life-threatening late effects. Yet <20%
of CCS receive recommended survivorship care, despite the availability of consensus guidelines for lifelong
surveillance for late effects starting 2 years post-therapy. The “gold standard” cancer center-based survivorship
clinic provides high-quality care to CCS who attend, but patients avoid reminders of their past cancer and lack
knowledge and self-efficacy for survivorship care. Other barriers include travel distance, inadequate insurance,
and out-of-pocket costs—these structural issues contribute to health disparities. Partnering with community
primary care provider (PCP) clinics in a shared model of care is a promising strategy to overcome these barriers,
but PCPs lack knowledge, self-efficacy, and interactive communication with the cancer center and are confused
about the division of care responsibilities. Our intervention is scalable and distance-based, is informed directly
by patient and PCP barriers and preferences from previous studies, and is boosted by a nationwide explosion in
telehealth services precipitated by the COVID-19 crisis. The proposed randomized controlled trial will enroll 240
CCS 2.0-4.0 years post-chemotherapy/radiation to investigate an innovative multi-level intervention (i.e.,
interpersonal and organizational levels) consisting of 1) patient survivorship education via telehealth with the
cancer center, 2) ongoing patient-tailored education program within the EHR's patient portal, 3) a structured
interactive phone communication between the cancer center and the PCP clinic (with 1-year follow-up call), and
4) an in-person visit with the PCP clinic for survivorship care. The comparison group will be randomized to an
in-person visit with their cancer center survivorship clinic. This study includes 4 centers with high proportions of
subgroups vulnerable to survivorship care disparities (i.e., rural, Black, Latinx, Spanish-speaking,
socioeconomically disadvantaged). Both groups will be asked to begin recommended surveillance for late effects
within 1-year post-randomization, separate from tumor recurrence monitoring by the primary oncologist. Our
Specific Aims are to Aim 1- Demonstrate patient completion of guideline-recommended surveillance tests in
intervention participants is not inferior, i.e. within 10%, to that in the comparison group; Aim 2- Achieve greater
1) patient knowledge, self-efficacy, and activation and 2) PCP knowledge and self-efficacy with survivorship care
among intervention participants and their PCPs compared to the comparison group; and Aim 3- Ascertain
process outcomes for the 1) patient and 2) PCP clinic. Outcomes will also be assessed among subgroups with
survivorship care disparities. Transformative Impact: If our intervention demonstrates patient completion of
recommended survivorship care comparable to cancer center survivorship clinic, our study has the enormous
potential to deliver recommended lifelong care to a larger proportion of CCS and reduce survivorship care
disparities, while engaging patients and PCPs to integrate survivorship care as part of overall, lifelong health
maintenance.
项目摘要
超过80%的儿童癌症存活(CC)会产生严重或威胁生命的晚期影响。 <20%
CCS获得了建议的生存护理,使命是终身共识指南
在治疗后2年开始对晚期效果的监视。 “金标准”癌症中心的生存
诊所为参加会议的CC提供了高质量的护理,但患者避免了过去的癌症和缺乏的癌症。
生存护理的知识和自我效能。其他障碍包括旅行距离,保险不足,
以及自付费用 - 这些结构性问题有助于健康分布。与社区合作
在共享的护理模型中,初级保健提供者(PCP)诊所是克服这些障碍的承诺策略,
但是PCP缺乏知识,自我有效和与癌症中心的互动交流,并且很困惑
关于护理责任的划分。我们的干预是可扩展的,基于距离的,直接通知
由患者和PCP障碍和先前研究的偏好,并在全国范围内爆炸来提高
Covid-19危机珍贵的远程医疗服务。拟议的随机对照试验将招募240
化学疗法/放射后CCS 2.0 - 4.0年,以研究创新的多层次干预措施(即
人际关系和组织级别)由1)通过远程医疗的患者生存教育组成
癌症中心,2)EHR患者门户内部正在进行的患者监管教育计划,3)结构化
癌症中心和PCP诊所之间的交互式电话通信(带1年的随访),以及
4)与PCP诊所进行生存护理的面对面访问。比较组将随机分为
与他们的癌症中心生存诊所的亲自访问。这项研究包括4个比例高的中心
亚组容易受到生存护理分布的影响(即粗糙,黑色,拉丁裔,说西班牙语,
在社会经济上处于不利地位)。两组将被要求开始推荐监视以备后效应
在随机后的1年内,与原发肿瘤学家的肿瘤复发监测分开。我们的
具体目的是针对1-证明患者完成指南示威的监视测试
干预参与者在比较组中不较低,即10%以内;目标2-实现更大
1)患者知识,自我效能和激活以及2)PCP知识和自我效能感与生存护理
与比较组相比,干预参与者及其PCP;并瞄准3-确定
1)患者和2)PCP诊所的过程结果。还将在子组之间评估结果
生存护理分布。变革性影响:如果我们的干预证明了患者的完成
推荐的生存护理与癌症中心的生存诊所相当,我们的研究具有巨大
将推荐的终身护理提供给更大比例的CCS并减少生存护理的潜力
差异是在吸引患者和PCP以整合生存护理的同时,作为整体健康状况的一部分
维护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NINA S KADAN-LOTTICK其他文献
NINA S KADAN-LOTTICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NINA S KADAN-LOTTICK', 18)}}的其他基金
Developing and Testing a Culturally Tailored Mobile Health and Social MediaPhysical Activity Intervention Among Adolescent and Young Adult ChildhoodCancer Survivors
开发和测试针对青少年和青年儿童癌症幸存者的文化定制移动健康和社交媒体体育活动干预
- 批准号:
10736526 - 财政年份:2023
- 资助金额:
$ 57.72万 - 项目类别:
BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
弥合信息鸿沟和差距,确保生存:旨在提高儿童癌症生存依从性的多层次干预的 BRIDGES 随机对照试验
- 批准号:
10274932 - 财政年份:2021
- 资助金额:
$ 57.72万 - 项目类别:
BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
弥合信息鸿沟和差距,确保生存:旨在提高儿童癌症生存依从性的多层次干预的 BRIDGES 随机对照试验
- 批准号:
10910674 - 财政年份:2021
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
10020359 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
10464453 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
9895223 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
10706322 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
BONE DENSITY IN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
小儿急性淋巴细胞白血病幸存者的骨密度
- 批准号:
6264297 - 财政年份:1998
- 资助金额:
$ 57.72万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Project ASTHMA - Aligning with Schools to Help Manage Asthma and Decrease Health Inequities
ASTHMA 项目 - 与学校合作,帮助管理哮喘并减少健康不平等
- 批准号:
10803747 - 财政年份:2023
- 资助金额:
$ 57.72万 - 项目类别:
Extraction of Vital Signs using a Telehealth Application for Asthma - EViTA-AThe purpose of this grant is to evaluate mobile devices to extract vitals signs to monitor patients with Asthma
使用哮喘远程医疗应用程序提取生命体征 - EViTA-A 这项拨款的目的是评估移动设备提取生命体征以监测哮喘患者
- 批准号:
10699530 - 财政年份:2023
- 资助金额:
$ 57.72万 - 项目类别:
Exploring, Predicting, and Intervening on Long-term Viral suppression Electronically (EPI-LoVE)
电子方式探索、预测和干预长期病毒抑制 (EPI-LoVE)
- 批准号:
10676683 - 财政年份:2023
- 资助金额:
$ 57.72万 - 项目类别:
Achieving Optimal Sexual and Reproductive Health (SRWH Project)
实现最佳性健康和生殖健康(SRWH 项目)
- 批准号:
10781706 - 财政年份:2023
- 资助金额:
$ 57.72万 - 项目类别: